持续促红细胞生成素受体激活剂诱发的皮肤白细胞破碎性血管炎。 - Suppr

Suppr

超能文献

Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator.

作者信息

Kwon Hyeok-Jin, Kim Jung-Hwan, Yoo Dong-Wha, Kim Tae-Hoon, Yoon Jung-Ho, Kim Ki-Ho

机构信息

Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.

出版信息

JAAD Case Rep. 2021 Aug 27;16:101-104. doi: 10.1016/j.jdcr.2021.08.027. eCollection 2021 Oct.

DOI:10.1016/j.jdcr.2021.08.027

PMID:34553012

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8441105/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e838/8441105/97959fe6b60b/gr1.jpg

相似文献

Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator.持续促红细胞生成素受体激活剂诱发的皮肤白细胞破碎性血管炎。

JAAD Case Rep. 2021 Aug 27;16:101-104. doi: 10.1016/j.jdcr.2021.08.027. eCollection 2021 Oct.

Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study.早期对持续红细胞生成素受体激动剂的反应可预测肾脏预后，并由非透析慢性肾脏病中的新型抗氧化标记物决定：一项前瞻性、观察性、单中心研究。

Clin Exp Nephrol. 2020 Jul;24(7):590-597. doi: 10.1007/s10157-020-01873-0. Epub 2020 Mar 17.

Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity-matched analysis.比较持续性促红细胞生成素受体激活剂与阿法达贝泊汀治疗日本慢性肾脏病患者透析前期的疗效：一项倾向匹配分析。

Nephrology (Carlton). 2015 Dec;20 Suppl 4:22-8. doi: 10.1111/nep.12641.

Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.LC-MS 法确证检测马血浆中的连续性促红细胞生成素受体激活剂和促红细胞生成素类似物用于兴奋剂检测。

Anal Chem. 2010 Nov 1;82(21):9074-81. doi: 10.1021/ac102031w. Epub 2010 Oct 14.

Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.甲氧基聚乙二醇-促红细胞生成素β作为一种新型促红细胞生成刺激剂，对非透析慢性肾脏病患者可能具有肾脏保护和心血管保护作用。

Curr Pharm Biotechnol. 2017;18(4):303-308. doi: 10.2174/1389201018666170127104801.

Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease-Induced Enlargement of Myocardial Infarct Size.促红细胞生成素受体配体的长期治疗可预防慢性肾脏病引起的心肌梗死面积扩大。

Hypertension. 2016 Sep;68(3):697-706. doi: 10.1161/HYPERTENSIONAHA.116.07480. Epub 2016 Jul 25.

Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease.晚期慢性肾病患者中持续促红细胞生成素受体激活剂（CERA）、达贝泊汀和促红细胞生成素之间的剂量等效性。

Hippokratia. 2014 Oct-Dec;18(4):315-8.

Time spent on erythropoietin stimulating agents administration in hemodialysis centers in Panama: a time and motion study.在巴拿马的血液透析中心，使用红细胞生成刺激剂的时间：一项时间和动作研究。

J Med Econ. 2019 Aug;22(8):736-741. doi: 10.1080/13696998.2019.1600527. Epub 2019 Apr 12.

Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator.血液透析开始前6个月使用促红细胞生成剂治疗贫血：达贝泊汀α与持续促红细胞生成素受体激活剂的比较

Keio J Med. 2017 Sep 26;66(3):44-50. doi: 10.2302/kjm.2016-0009-OA. Epub 2016 Dec 19.

Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials.非透析依赖性慢性肾脏病患者对聚乙二醇化促红细胞生成素β的反应性与肾脏生存之间的关联：来自临床试验个体患者水平数据的汇总分析

Nephrology (Carlton). 2017 Oct;22(10):769-775. doi: 10.1111/nep.12842.

本文引用的文献

Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.抗体介导的与红细胞生成素-β聚乙二醇（C.E.R.A.）相关的纯红细胞再生障碍：一例透析患者的病例报告。

BMC Nephrol. 2020 Jul 14;21(1):275. doi: 10.1186/s12882-020-01934-2.

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation.聚乙二醇替代物在克服药物递送和生物偶联中聚乙二醇免疫原性方面的重要性。

Polymers (Basel). 2020 Feb 2;12(2):298. doi: 10.3390/polym12020298.

Anaphylaxis following the intravenous administration of continuous erythropoietin receptor activator in a haemodialysis patient.一名血液透析患者静脉注射持续促红细胞生成素受体激活剂后发生过敏反应。

Nephrology (Carlton). 2014 May;19(5):304. doi: 10.1111/nep.12213.

Immunogenicity of therapeutic proteins: influence of aggregation.治疗性蛋白质的免疫原性：聚集的影响。

J Immunotoxicol. 2014 Apr-Jun;11(2):99-109. doi: 10.3109/1547691X.2013.821564. Epub 2013 Aug 6.

The immunogenicity of polyethylene glycol: facts and fiction.聚乙二醇的免疫原性：事实与虚构。

Pharm Res. 2013 Jul;30(7):1729-34. doi: 10.1007/s11095-013-1067-7. Epub 2013 May 15.

Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.促红细胞生成素刺激剂的区别因素：更新用于慢性肾脏病贫血的选择。

Drugs. 2013 Feb;73(2):117-30. doi: 10.1007/s40265-012-0002-2.

Erythropoietins: a common mechanism of action.促红细胞生成素：一种共同的作用机制。

Exp Hematol. 2008 Dec;36(12):1573-84. doi: 10.1016/j.exphem.2008.08.003. Epub 2008 Oct 14.

Immunogenicity of biopharmaceuticals.生物制药的免疫原性。

Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v9-12. doi: 10.1093/ndt/gfl476.

Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis.皮肤血管炎最新进展：诊断标准、分类、流行病学、病因、发病机制、评估及预后

Am J Dermatopathol. 2005 Dec;27(6):504-28. doi: 10.1097/01.dad.0000181109.54532.c5.

Cutaneous and systemic manifestations of drug-induced vasculitis.药物性血管炎的皮肤及全身表现

Ann Pharmacother. 2002 Jan;36(1):130-47. doi: 10.1345/aph.1A124.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验